Can C-Section risk be Predicted in Nulliparous Women?
This study by Burke et al. (AJOG, 2017) aimed to determine if it is possible to use maternal and fetal, clinical, anthropomorphic, and ultrasound information to create a tool to predict the risk of C-section before onset of labor in nulliparous women.
Blinded prospective multicenter national study
2,336 nulliparous women were recruited for this study as part of the Genesis trial. Entrance criteria included vertex presentation between 39+0 and 40+6 weeks’ gestation. Study subjects underwent a detailed clinical evaluation and prenatal ultrasound examination. All hypothetical risk factors were assessed together as a composite score. 491 (21%) of the women had an unplanned C-section. It was determined that advancing maternal age, shorter maternal height, increasing BMI, larger fetal abdominal circumference, and larger fetal head circumference were the best combined predictors to be used in the nomogram to predict C-section risk. The authors suggest that this approach to risk calculation can be used to stratify women into a low risk/reassurance group or those who should avoid trial of labor.
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan